Alternative proteins and EU food law

Summary

We ask how European food law impacts the transformative potential of alternative proteins, including single-cell proteins, plant-based novel proteins, cultured meat,macroalgae, and insects. The Novel Food Regulation may prove insurmountable for small companies, and it is demanding and time-consuming even for larger companies,dampening the transformative potential of all novel foods and traditional foods from third countries. Several microalgae and macroalgae are non-novel in the EU, which eases their way into the markets. The unclear novel food status of some potential green macroalgae species is a hindrance. All insects are novel, and none has EU-level authorization yet, although some Member States allow insect food. The GM Food Regulation is procedurally and scientifically demanding, and

Regional applicability

This analysis is directly applicable to United Kingdom food policy and industry, though post-Brexit regulatory divergence must be considered: the UK retained EU food law frameworks but has since begun independent reforms through the Food Standards Authority and may pursue distinct pathways for alternative protein regulation. The identified barriers and opportunities remain relevant to UK market development strategies.

Key measures

Regulatory status and authorization timelines for alternative protein categories under EU law; barriers to market entry; labelling and health claims requirements

Outcomes reported

The study examined how EU food law frameworks (Novel Food Regulation, GM Food Regulation, naming and labelling rules) impact the market development and transformative potential of alternative proteins including single-cell proteins, plant-based proteins, cultured meat, macroalgae, and insects. It identifies regulatory barriers and variations in authorization status across different protein categories and EU Member States.

Topic tags